Researchers at Vanderbilt University Medical Center and the University of Alberta in Canada have identified a biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely ...
Dec 05, 2013
not rated yet | 0 |
Study shows benefits for men with metastatic prostate cancer who receive chemotherapy when starting hormone therapy
Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, ...
Dec 06, 2013
not rated yet | 0